Does Zevra Therapeutics (ZVRA) Have the Potential to Rally 117.11% as Wall Street Analysts Expect?

Shares of Zevra Therapeutics (ZVRA) have gained 16.8% over the past four weeks to close the last trading session at $10.99, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.86 indicates a potential upside of 117.1%.The mean estimate comprises seven short-term price targets with a standard deviation of $3.39. While the lowest estimate of $19.00 indicates a 72.9% increase from ...